Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
In addition, Zacks Equity Research provides analysis on — Pfizer Inc.'s PFE. Here is a synopsis of all three stocks: Broadcom is a Zack Rank #1 (Strong Buy) that is a powerhouse in the semiconductor and infrastructure software industries. As AI adoption accelerates and demand for high-speed connectivity surges, Broadcom stands to benefit from increased enterprise spending and data center expansion. Despite strong earnings momentum in recent quarters, the stock has been trading sideways. However, rising earnings estimates and solid technical support suggest underlying strength. With a history of strategic acquisitions and a focus on high-margin businesses, Broadcom remains a compelling opportunity for investors looking for long-term growth. Broadcom has established itself as a leader in high-performance semiconductor solutions while expanding its footprint in infrastructure software, cybersecurity, and networking. The company employs 37,000 people and has a market cap of $9
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer [Yahoo! Finance]Yahoo! Finance
- Jim Cramer on Pfizer: “I'm Going to Say Just Weak Hold” [Yahoo! Finance]Yahoo! Finance
- BeOne Medicines names R&D chief Wang Lai as co-president to lead global expansion [Yahoo! Finance]Yahoo! Finance
- Better Buy in 2026: Pfizer or Merck? [Yahoo! Finance]Yahoo! Finance
- Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/17/25 - Form 4
- 12/16/25 - Form 8-K
- 12/2/25 - Form 4
- PFE's page on the SEC website